New drug combo shows promise for tough lung cancer
NCT ID NCT04602533
First seen Mar 13, 2026 · Last updated May 22, 2026 · Updated 10 times
Summary
This study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can help people with limited-stage small cell lung cancer live longer without their cancer growing. About 105 adults with this specific type of lung cancer will receive either the standard treatment or the standard treatment plus durvalumab, followed by maintenance durvalumab. The main goal is to see if the combination improves progression-free survival after 18 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER LIMITED STAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asklepios Fachkliniken Muenchen Gauting
München Gauting, Bavaria, 82131, Germany
-
Asklepios Klinikum Hamburg
Hamburg, 21075, Germany
-
Helios Kliniken Erfurt
Erfurt, Thuringia, 99089, Germany
-
Johannes Wesling Klinikum Minden
Minden, North Rhine-Westphalia, 32429, Germany
-
KEM GmbH
Essen, North Rhine-Westphalia, 45136, Germany
-
Klinikum Ernst von Bergmann
Potsdam, Brandenburg, 14467, Germany
-
Klinikum Kassel GmbH-Klinik für Onkologie und Hämatologie
Kassel, Hesse, 34125, Germany
-
Klinikverbund Allgäu gGmbH
Immenstadt im Allgäu, Bavaria, 87509, Germany
-
Lungenklinik Hemer
Hemer, North Rhine-Westphalia, 58675, Germany
-
Lungenklinik Köln-Merheim
Cologne, North Rhine-Westphalia, 51109, Germany
-
Sana-Klinikum Offenbach
Offenbach, Hesse, 63069, Germany
-
Universitätsklinikum Aachen
Aachen, North Rhine-Westphalia, 52074, Germany
-
Universitätsklinikum Essen
Essen, North Rhine-Westphalia, 45147, Germany
-
Universitätsklinikum Gießen Marburg
Giessen, Hesse, 35392, Germany
-
Universitätsmedizin Rostock
Rostock, Mecklenburg-Vorpommern, 18059, Germany
Conditions
Explore the condition pages connected to this study.